Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.

MD, Snape; T, Dawson; P, Oster; A, Evans; TM, John; B, Ohene-Kena; J, Findlow; LM, Yu; R, Borrow; E, Ypma; D, Toneatto; AJ, Pollard

doi:10.1097/inf.0b013e3181f59f6d

Public

Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.

Shared by NobleBlocks on Nov 1, 2010 • 12:00 AM UTC

Authors:

Snape MD

Dawson T

Oster P

Abstract

Background An investigational vaccine against serogroup B meningococcal (MenB) disease containing 3 main recombinant proteins (factor H-binding protein, Neisserial adhesion A, and Neisserial heparin-binding antigen) has been developed. We evaluated the immunogenicity and reactogenicity of a 3-dose c...

Discussions